Navarro offers information about ACA
MIAMI — Navarro Discount Pharmacy is reaching out as an information resource about the implementation and rollout of the Patient Protection and Affordable Care Act, the 33-store chain said Wednesday.
Navarro, based in Miami and the largest Hispanic-owned pharmacy chain in the country, said several healthcare companies would be available at its stores to explain insurance options, costs and other important information. The chain also will offer free health screenings like glucose testing, blood-pressure monitoring and others.
"Our continuing goal is to provide options to our customers and assist them in any way we can to make informed decisions," said Manuel Leon, VP of Navarro subsidiary OTC Health Solutions; more than half a million members of the subsidiary receive benefits through insurance companies for OTC health products. "As a community pharmacy, our customers already have strong relationships with our pharmacists, who are the logical choices to liaison with customers and insurance company representatives when healthcare questions arise."
The company also will support a community-wide healthcare education effort for Hispanics by sponsoring Univision’s "Salud es Vida" event, which will take place on Saturday and Sunday at the Miami-Dade County Fair and Expo. The event will provide consumers with up-to-date information on the options available under Florida’s health insurance marketplace, with health insurance companies, community pharmacies, government officials, local radio and television personalities and healthcare providers attendees and free health screenings, exercise demonstrations and healthy cooking instructions.
California expands scope of pharmacy practice
SACRAMENTO, Calif. — Along with a number of Patient Protection and Affordable Care Act-themed pieces of legislation, California Gov. Jerry Brown on Tuesday signed into law a provision that will allow pharmacists to perform physical assessments; order and interpret laboratory tests; refer patients to other providers; start, adjust and terminate medications under physician protocol; and work with other healthcare providers to evaluate and manage a patient’s health issues.
"This legislation will take important steps to allow pharmacists to provide patients care at a level they are educated and fully capable of providing," the National Community Pharmacists Association stated in a blog. "The bill also is notable for its collaborative approach to other healthcare providers. It is supported by many healthcare-related organizations including the California Association for Nurse Practitioners, the California Association of Physician Groups and the California Hospital Association."
"Hopefully adoption of this legislation by the most populous U.S. state will prompt more states to enact similar legislation in the coming months," the association added.
Actavis appoints board of directors for Irish division following Irish High Court clearance of Warner Chilcott deal
DUBLIN — Actavis has appointed the board of directors for the division it recently created as part of its acquisition of Ireland-based Warner Chilcott, the drug maker said.
Actavis, which announced the $8.5 billion purchase of Warner Chilcott, cleared the final regulatory hurdle to the acquisition Monday when the Irish High Court approved it. As part of the acquisition, it is changing Warner Chilcott’s name to Actavis plc.
The board of directors includes Actavis president and CEO Paul Bisaro; Warner Chilcott board member James Bloem; Actavis board member and retired president of healthcare services for CVS Caremark Christopher Bodine; Warner Chilcott board member Tamar Howson; Warner Chilcott non-executive board chairman John King; Actavis board member Catherine Klema; former Zentiva chairman and CEO Jiri Michal; Actavis board member Jack Michelson; Actavis Pharma president Sigurdur Oli Olafsson, who oversees the company’s generic, branded generic, legacy brands and OTC business; Warner Chilcott board member Patrick O’Sullivan; Actavis board member Ronald Taylor; Actavis board member Andrew Turner; and Actavis board member Fred Weiss.
The board’s appointment is effective until the next annual meeting of shareholders, which will take place in May 2014.